Laddar...

Pegvisomant in acromegaly: an update

BACKGROUND: In 2007, we published an opinion document to review the role of pegvisomant (PEG) in the treatment of acromegaly. Since then, new evidence emerged on the biochemical and clinical effects of PEG and on its long-term efficacy and safety. AIM: We here reviewed the emerging aspects of the us...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Endocrinol Invest
Huvudupphovsmän: Giustina, A., Arnaldi, G., Bogazzi, F., Cannavò, S., Colao, A., De Marinis, L., De Menis, E., Degli Uberti, E., Giorgino, F., Grottoli, S., Lania, A. G., Maffei, P., Pivonello, R., Ghigo, E.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer International Publishing 2017
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5443862/
https://ncbi.nlm.nih.gov/pubmed/28176221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40618-017-0614-1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!